Table 4 Use of drugs in the main ATC groups and the estimated annual drug cost per person in persons with dementia stratified by residential settinga
From: The impact of dementia on drug costs in older people: results from the SNAC study
Main ATC group | Community-dwelling | Institution | |||
(n=124a) | (n=195) | ||||
Use (%) | Cost SEK | Use (%) | Cost SEK | ||
A | Alimentary tract and metabolism | 41.3 | 569 | 59.5 | 929 |
B | Blood and blood forming agents | 41.3 | 237 | 50.8 | 201 |
C | Cardiovascular system | 42.8 | 578 | 59.0 | 473 |
D | Dermatologicals | 4.7 | 24 | 14.9 | 94 |
G | Genito urinary system and sex hormones | 12.7 | 297 | 14.4 | 230 |
H | Systemic hormonal preparations, excl. sex hormones | 10.3 | 9 | 16.4 | 60 |
J | General anti-infectives for systemic use | 0.8 | 1 | 6.7 | 18 |
L | Antineoplastic and immunomodulating agents | 1.6 | 235 | 1.0 | 5 |
M | Musculo-skeletal system | 6.3 | 136 | 9.7 | 137 |
N | Nervous system | 44.4 | 2,291 | 81.0 | 3,782 |
P | Antiparasitic products | 1.6 | 486 | 1.5 | 440 |
R | Respiratory system | 5.5 | 89 | 17.1 | 362 |
S | Sensory organs | 7.9 | 59 | 8.7 | 139 |
V | Various | - | - | - | |
Totalb | 66.9 | 5,011 | 88.7 | 6,869 | |